The main purpose of this legislation is to enhance the informed consent process for veterans receiving certain types of medications. It aims to ensure that veterans are fully aware of the risks and benefits associated with these medications before they agree to treatment. The key provisions of this legislation require the Secretary of Veterans Affairs to update existing guidelines related to informed consent, specifically VHA Directive 1005, which currently focuses on long-term opioid therapy for pain.